CNTA- Centessa Pharmaceuticals Plc

Name: Centessa Pharmaceuticals Plc Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Centessa Pharmaceuticals Plc (CNTA) has 12 insiders with recent SEC Form 4 filings, including 23 buys and 2 sells. CNTA is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
Other	Bush Tia L	360.3K	$14.31M	-
CEO	Saha Saurabh	276.0K	$10.96M	-
CEO	Accardi Mario Alberto	243.3K	$9.66M	-
Other	Hussain Iqbal J	105.4K	$4.19M	-
Other	Weinhoff Gregory M	89.9K	$3.57M	-

Activity

Buys and sells only

Transactions

10 filings · page 10

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
May 18, 2022	Yver Antoine46	EVP &Chairman Of Development	Sell	85,000	$5.17	$439,733.76	-5.2%	-15.2%	-12.9%
Feb 2, 2022	Saha Saurabh	Chief Executive Officer	Buy	5,000	$9.74	$48,700.00	+21.7%	-8.5%	-59.5%
Jan 28, 2022	Grainger David J	Chief Innovation Officer	Buy	27,500	$9.05	$248,754.00	New	-5.0%	-59.4%
Dec 2, 2021	De Rubertis Francesco	Director	Buy	34,326	$12.82	$440,059.32	+0.9%	-31.0%	-69.7%
Dec 2, 2021	Medicxi Ventures Management (jersey) Ltd	10% Owner	Buy	34,326	$12.82	$440,059.32	+0.9%	-31.0%	-69.7%
Dec 1, 2021	Medicxi Ventures Management (jersey) Ltd	10% Owner	Buy	97,151	$12.24	$1,189,198.62	+1.2%	-29.1%	-67.6%
Dec 1, 2021	De Rubertis Francesco	Director	Buy	97,151	$12.24	$1,189,198.62	+1.2%	-29.1%	-67.6%
Nov 29, 2021	De Rubertis Francesco	Director	Buy	68,523	$11.64	$797,426.45	+0.9%	-22.8%	-66.3%
Nov 29, 2021	Medicxi Ventures Management (jersey) Ltd	10% Owner	Buy	68,523	$11.64	$797,426.45	+0.9%	-22.8%	-66.3%
Nov 18, 2021	Kantoff Aaron	Director	Buy	10,000	$11.99	$119,850.00	+20.0%	-16.7%	-70.4%

← PrevPage 10Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC